Ping Liu

1200 Cailun Road
Shanghai, 201203, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 193 publications

Correction: Fuzheng Huayu formula ameliorates chronic cholestatic liver injury by upregulating PPARa in mice.

Correction: Fuzheng Huayu formula ameliorates chronic cholestatic liver injury by upregulating PPARa in mice.

Journal: Chinese medicine
Published: May 14, 2026

Mechanically reinforced black TiO2 nanocomposite hydrogels with NIR-triggered photothermal/photodynamic antibacterial therapy effect.

Mechanically reinforced black TiO2 nanocomposite hydrogels with NIR-triggered photothermal/photodynamic antibacterial therapy effect.

Journal: Biomaterials advances
Published: April 28, 2026

Correction: The novel Chinese medicine JY5 formula alleviates hepatic fibrosis by inhibiting the notch signaling pathway.

Correction: The novel Chinese medicine JY5 formula alleviates hepatic fibrosis by inhibiting the notch signaling pathway.

Journal: Frontiers in pharmacology
Published: April 13, 2026

Drug Development for MASH-Related Compensated Cirrhosis: Past, Present and Future.

Drug Development for MASH-Related Compensated Cirrhosis: Past, Present and Future.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 01, 2026

Salvianolic acid B ameliorates metabolic dysfunction-associated steatohepatitis in mice by inhibiting hepatocyte ferroptosis via regulation of the SIRT1/p53 axis.

Salvianolic acid B ameliorates metabolic dysfunction-associated steatohepatitis in mice by inhibiting hepatocyte ferroptosis via regulation of the SIRT1/p53 axis.

Journal: Free radical biology & medicine
Published: January 15, 2026

Senkyunolide H potentiates bone marrow-derived mesenchymal stem cells therapy for liver cirrhosis by targeting MAEA to enhance ERK-driven HGF secretion.

Senkyunolide H potentiates bone marrow-derived mesenchymal stem cells therapy for liver cirrhosis by targeting MAEA to enhance ERK-driven HGF secretion.

Journal: Pharmacological research
Published: January 03, 2026

Fuzheng Huayu formula attenuates ductular reaction and liver fibrosis potentially through suppressing Gli1 pathway.

Fuzheng Huayu formula attenuates ductular reaction and liver fibrosis potentially through suppressing Gli1 pathway.

Journal: Journal of ethnopharmacology
Published: December 23, 2025

Synergistic amelioration of cholestatic liver fibrosis by combined total astragalus saponins and AAV8.Numb-Exon3 through modulation of hepatic progenitor cell differentiation.

Synergistic amelioration of cholestatic liver fibrosis by combined total astragalus saponins and AAV8.Numb-Exon3 through modulation of hepatic progenitor cell differentiation.

Journal: Frontiers in pharmacology
Published: December 07, 2025

Isoastragaloside II modulates PPAR-α/FXR signaling and bile acid metabolism to ameliorate cholestatic liver diseases (CLD).

Isoastragaloside II modulates PPAR-α/FXR signaling and bile acid metabolism to ameliorate cholestatic liver diseases (CLD).

Journal: European journal of pharmacology
Published: December 01, 2025

Multimodal tumor thermal therapy enhances antitumor immunity by expanding tumor-reactive CX3CR1⁺GPR56⁺ T cells in hepatocellular carcinoma.

Multimodal tumor thermal therapy enhances antitumor immunity by expanding tumor-reactive CX3CR1⁺GPR56⁺ T cells in hepatocellular carcinoma.

Journal: Theranostics
Published: November 06, 2025

A metabolite-augmented FIB-4 machine learning panel achieves superior liver fibrosis staging in chronic liver disease.

A metabolite-augmented FIB-4 machine learning panel achieves superior liver fibrosis staging in chronic liver disease.

Journal: Cell reports. Medicine
Published: November 05, 2025

Research Progress on Biliary Stent Materials and Coatings.

Research Progress on Biliary Stent Materials and Coatings.

Journal: ACS applied bio materials
Published: November 03, 2025
Showing 1-12 of 193

Last Updated: 09/26/2026